# An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland

> **NCT00236990** · PHASE2 · COMPLETED · sponsor: **McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.** · enrollment: 283 (actual)

## Conditions studied

- Prostatitis

## Interventions

- **DRUG:** pentosan polysulfate sodium

## Key facts

- **NCT ID:** NCT00236990
- **Lead sponsor:** McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2011-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236990, "An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00236990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*